论文部分内容阅读
目的:探讨替米沙坦联合依那普利治疗肾性高血压的临床效果及其对肾脏的保护作用。方法:选取在我院接受治疗的100位肾性高血压患者,将其随机分为治疗组及对照组,平均每组50人,对照组采用常规替米沙坦治疗,治疗组则采用替米沙坦联合依那普利治疗,连续治疗2个月,观察临床结果。结果:治疗组的治疗效果明显高于对照组,且不良反应也比较低。结论:通过对比,发现替米沙坦联合依那普利治疗肾性高血压的效果相对较好,同时在一定程上可有效保护患者的肾脏功能。
Objective: To investigate the clinical effect of telmisartan combined with enalapril in the treatment of renal hypertension and its protective effect on the kidney. Methods: A total of 100 hypertensive patients with renal hypertension who were treated in our hospital were randomly divided into treatment group and control group with an average of 50 in each group. The control group was treated with telmisartan, while the treatment group was treated with telmisartan Satan combined enalapril treatment, continuous treatment for 2 months to observe the clinical results. Results: The treatment group was significantly higher than the control group, and adverse reactions are relatively low. CONCLUSIONS: By contrast, telmisartan combined with enalapril has shown relatively good results in the treatment of renal hypertension and, at the same time, has been shown to be effective in protecting renal function in some patients.